Skip to content

Adherence to Prescribed Medication: Elucidating the Gap Between Guideline Recommendation and Real Life in Myocardial Infarction

Adherence to Prescribed Medication: Elucidating the Gap Between Guideline Recommendation and Real Life in Myocardial Infarction

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03661710
Acronym
COMPLY
Enrollment
300
Registered
2018-09-07
Start date
2019-01-30
Completion date
2023-01-30
Last updated
2019-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adherence, Medication, Myocardial Infarction

Brief summary

The aim of the study is to investigate the adherence to prescribed post-infarction medication and to cardiac rehabilitation in patients after acute myocardial infarction. In addition, their impact on cardiovascular events will be investigated.

Interventions

OTHERInvestigating Adherence to Standard of Care Medication and Cardiac Rehabilitation

Information from health care insurance providers on how many patients adhered to prescribed medication and how many underwent cardiac rehabilitation and how adherence influenced cardiovascular outcome will be retrieved

Sponsors

Medical University of Vienna
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Acute myocardial infarction * Willingness to participate

Exclusion criteria

* Inclusion in an interventional study interfering with standard of care medication

Design outcomes

Primary

MeasureTime frameDescription
Cardiovascular Event3 yearsComposite of re-hospitalization due to acute MI, heart failure, stent thrombosis, fatal MI, and overall mortality

Countries

Austria

Contacts

Primary ContactAndreas Kammerlander, MD PhD
andreas.kammerlander@meduniwien.ac.at+43140400

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026